Loading data
UNCYNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 675 k USD | 951 k USD | — |
| Research and development expense | 9.12 m USD | 20.01 m USD | 12.9 m USD | 12.44 m USD | 6.08 m USD |
| Selling, general and administrative expense | — | — | — | 383 k USD | 245 k USD |
| Operating profit | -29.52 m USD | -32.12 m USD | -20.77 m USD | -18.05 m USD | -8.98 m USD |
| Interest expense | — | — | 82 k USD | 6 k USD | 628 k USD |
| Net income (reported basis) | -26.56 m USD | -36.73 m USD | -30.54 m USD | -18.06 m USD | -10.02 m USD |
| Net income attributable to common shareholders | -26.56 m USD | -37.82 m USD | -31.41 m USD | -18.06 m USD | -10.02 m USD |
| Basic earnings per share | -1.67 USD/share | -5.65 USD/share | -1.28 USD/share | -1.2 USD/share | -0.86 USD/share |
| Diluted earnings per share | -1.67 USD/share | -5.65 USD/share | -1.28 USD/share | -1.2 USD/share | -0.86 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.